date,title,source
Oct-22-18,Why Nektar Therapeutics Crashed 17.2% Today,Motley Fool
Oct-22-18,Why Mirati Therapeutics Inc. Is Plunging Today,Motley Fool
Oct-22-18,"Microsoft's typical worker makes $168K a year  how that compares with Facebook, Google, PayPal, Box, Salesforce, Intel and other big Bay Area tech employers",American City Business Journals
Oct-23-18,Todays Research Reports on Stocks to Watch: Tesaro and Nektar Therapeutics,ACCESSWIRE
Oct-24-18,Implied Volatility Surging for Nektar Therapeutics (NKTR) Stock Options,Zacks
Oct-24-18,"New Research Coverage Highlights Nektar Therapeutics, General Mills, Yelp, Zillow Group, Tutor Perini, and Hormel Foods  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Oct-30-18,EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Nektar Therapeutics  NKTR,Business Wire
Oct-30-18,"Pomerantz Law Firm Announces the Filing of a Class Action against Nektar Therapeutics, Inc. and Certain Officers  NKTR",GlobeNewswire
Oct-30-18,"Nektar to Announce Financial Results for the Third Quarter 2018 on Wednesday, November 7, 2018, After Close of U.S.-Based Financial Markets",PR Newswire
Oct-31-18,Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Nektar Therapeutics (NKTR),GlobeNewswire
Oct-31-18,"CLASS ACTION UPDATE for TGTX, HAS and NKTR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",GlobeNewswire
Oct-31-18,"IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nektar Therapeutics and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",GlobeNewswire
Oct-31-18,"Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Nektar Therapeutics (NKTR) and Encourages NKTR Investors to Contact the Firm",GlobeNewswire
Nov-01-18,SHAREHOLDER ALERT: SKX QRTEA MCHP TGTX ALNY HAS CPB TRVN HTHT NKTR: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,GlobeNewswire
Nov-01-18,"INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nektar Therapeutics and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",Business Wire
Nov-01-18,Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against Nektar Therapeutics (NKTR),Business Wire
Nov-05-18,"INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nektar Therapeutics and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",GlobeNewswire
Nov-05-18,SHAREHOLDER ALERT: PVG USAT COCP JT GOOG OZK NKTR FIT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,GlobeNewswire
Nov-05-18,Is Nektar Therapeutics (NASDAQ:NKTR) Worth US$39.05 Based On Intrinsic Value?,Simply Wall St.
Nov-05-18,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Nektar Therapeutics, Inc. (NKTR) & Lead Plaintiff Deadline: December 31, 2018",ACCESSWIRE
Nov-05-18,What's in the Cards for Nektar (NKTR) This Earnings Season?,Zacks
Nov-06-18,"Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Nektar Therapeutics",GlobeNewswire
Nov-06-18,Dow Gains 173 Points Because the Market Only Cares That Midterms Are Almost Over,Barrons.com
Nov-06-18,"The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TRVN, HON, OZK and NKTR",GlobeNewswire
Nov-06-18,Why Nektar Therapeutics Tumbled 10% Today,Motley Fool
Nov-06-18,NKTR LOSS ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Nektar Therapeutics; Important Deadline  NKTR,GlobeNewswire
Nov-06-18,"IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nektar Therapeutics and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Nov-06-18,"NEKTAR INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Nektar Therapeutics To Contact The Firm",Business Wire
Nov-06-18,"New Clinical Oncology Collaboration Between Nektar and Pfizer to Evaluate Combination of NKTR-214, a CD122-Biased Agonist, with Avelumab and Talazoparib or Enzalutamide in Multiple Cancers",PR Newswire
Nov-06-18,Nektar Therapeutics to Host Webcast Conference Call with Melanoma Specialists for Analysts & Investors During 2018 Society for Immunotherapy of Cancer 33rd Annual Meeting,PR Newswire
